Streetbeat News

Products Services

SGMO

Sangamo Therapeutics' stock is trading higher following the announcement of FDA alignment on an abbreviated pathway for potential approval and EMA PRIME eligibility for its ST-920 treatment in Fabry disease.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 3:51 pm

NNOX

Nano-X AI has received FDA 510(k) approval for its HealthFLD system, designed to detect early signs of fatty liver disease. This regulatory milestone could significantly impact the company's market positioning and product deployment strategy in the healthcare sector.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 3:49 pm

BMR

NVDA

Beamr Imaging Ltd. (NASDAQ:BMR) shares surged after announcing a collaboration with Nvidia Corporation (NASDAQ:NVDA) to present joint research on automated video modernization at the ACM Mile-High-Video 2024 conference. The research focuses on transitioning video libraries to the AV1 format using Nvidia's hardware, addressing challenges of compute power and video quality maintenance. Beamr's stock has seen a significant increase, trading up 311% at $8.68.

Portfolio Pulse from Erica Kollmann

February 12, 2024 | 3:37 pm

CLSK

MARA

RIOT

Shares of Bitcoin mining companies Marathon Digital Holdings Inc (MARA), Riot Platforms Inc (RIOT), and CleanSpark Inc (CLSK) are trading higher amid a rise in Bitcoin prices and earnings optimism. Bitcoin's price increase is attributed to institutional adoption and excitement over the upcoming halving event. CleanSpark's recent earnings report and the anticipation of Riot's and Marathon's upcoming earnings are also influencing stock prices.

Portfolio Pulse from Adam Eckert

February 12, 2024 | 3:33 pm

NGD

New Gold (AMEX:NGD) announced a three-year plan to increase gold and copper production by 35% and 60% respectively by 2026. The Toronto-based company aims to achieve this through higher output at its current mines and completing growth projects, expecting significant free cash flow generation as costs decrease. The plan includes boosting gold production to between 410,000 and 460,000 ounces, and copper to between 71 million and 81 million pounds, with the first results expected in 2024. New Gold anticipates $75 million in free cash flow in the second half of the year, with $185.9 million in cash and $395.7 million in debt currently.

Portfolio Pulse from Stjepan Kalinic

February 12, 2024 | 3:21 pm

LUNR

Intuitive Machines, Inc. (NASDAQ:LUNR) stock has surged over 60% in the past five days, following the announcement that its IM-1 mission Nova-C class lunar lander is ready for launch. The launch, part of NASA's Artemis program, is scheduled for Feb. 14. The stock's trading volume has significantly exceeded its 100-day average, and it has an average 1-year price target of $7.0, indicating a potential upside of 19.05%. Analysts hold bullish views on the stock, with price targets ranging from $4 to $10.

Portfolio Pulse from Erica Kollmann

February 12, 2024 | 3:01 pm

ACDC

ProFrac Holding Corp. has announced its operational and strategic priorities for 2024, focusing on higher utilization, enhancing customer experience, and maintaining low per unit costs. The announcement reflects the company's commitment to operational excellence and cost efficiency.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 2:36 pm

ANET

FTNT

JNPR

META

NVDA

PANW

Nvidia Inc (NVDA) and Meta Platforms Inc (META) are leading the S&P 500 in 2024, continuing their strong performance from 2023, driven by AI anticipation. Despite concerns of an AI "baby bubble", stocks outside the Magnificent 7 like Palo Alto Networks (PANW), Fortinet (FTNT), Juniper Networks (JNPR), and Arista Networks (ANET) are also performing well, with significant gains and positive earnings reports, highlighting the importance of AI in cybersecurity and networking.

Portfolio Pulse from Neil Dennis

February 12, 2024 | 2:35 pm

AAPL

An Apple Insider analysis has debunked concerns about RF radiation from the Wi-Fi and Bluetooth chips in Apple's Vision Pro being harmful. It clarified that RF radiation is different from ionizing radiation, which is harmful, and highlighted that the RF radiation levels from the device are much lower than those that could cause tissue damage. Both WHO and FDA have confirmed no scientific evidence suggests that weak RF signals from electronic devices can cause adverse health effects. The report reassures Apple Vision Pro users that the risk of RF radiation exposure is minimal.

Portfolio Pulse from Rounak Jain

February 12, 2024 | 2:29 pm

CBAY

GILD

Gilead Sciences Inc (NASDAQ:GILD) is acquiring CymaBay Therapeutics Inc (NASDAQ:CBAY) for $4.3 billion, or $32.50 per share in cash. This acquisition enhances Gilead's liver disease portfolio with CymaBay's lead product candidate, seladelpar, for primary biliary cholangitis (PBC). Seladelpar has shown promising results in Phase 3 trials and has received FDA priority review. The deal is expected to close in Q1 2024, with potential revenue growth and EPS neutrality in 2025 for Gilead.

Portfolio Pulse from Vandana Singh

February 12, 2024 | 2:22 pm